Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus

Current Biology

Volumn 8, Issue 1, 1998, Pages 19-25

  Rogove, A D ^a   Tsirka, S E ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0031963497     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(98)70016-8     Document Type: Article

References (32)

1. Wood P: Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol Res 1995, 17:242-248.
2. Zhang S, Fedoroff S: Neuron-microglia interactions in vitro. Acta Neuropathol 1996, 91:385-395.
3. Kreutzberg G: Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312-318.
4. Kreutzberg G: Microglia, the first line of defense in brain pathologies. Arzneim-Forsch/Drug Res 1995, 45:357-360.
5. Bruce A, Boling W, Kindy M, Peschon J, Kraemer P, Carpenter M, et al.: Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med 1996, 2:788-794.
6. Elkabes S, DiCicco-Bloom E, Black I: Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci 1996, 16:2508-2521.
7. Andersson P, Perry V, Gordon S: The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 1991, 42:201-214.
8. Fine S, Angel R, Perry S, Epstein L, Rothstein J, Dewhurst S, Gelbard H: Tumor necrosis factor alpha inhibits glutamake uptake by primary human astrocytes - implications for pathogenesis of HIV-1 dementia. J Biol Chem 1996, 271:15303-15306.
9. Lipton S, Rosenberg P: Excitatory amino acids as a final common pathway for neurological disorders. In Mechanisms of Disease. New Eng J Med 1994, 330:613-622.
10. Streit W, Morioka T, Kalehua A: MK-801 prevents microglial reaction in the rat hippocampus after forebrain ischemia. Neuroreport 1992, 3:146-148.
11. Lees G: The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J Neurol Sci 1993, 114:119-122.
12. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R et al.: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994, 368:419-424.
13. Tsirka S, Gualandris A, Amaral D, Strickland S: Excitotoxin induced neuronal degeneration and seizure are mediated by tissue-type plasminogen activator. Nature 1995, 377:340-344.
14. Auriault C, Joseph M, Tartar A, Capron A: Characterization and synthesis of a macrophage inhibitory peptide from the second constant domain of human immunoglobulin G. FEBS Lett 1983, 153:11-15.
15. Thanos S, Mey J, Wild M: Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci 1993, 13:455-466.
16. Tsirka S, Rogove A, Strickland S: tPA and neuronal death. Nature 1996, 384:123-124.
17. Tsirka S, Rogove A, Bugge T, Degen J, Strickland S: An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 1997, 17:543-552.
18. Miller L, Johnson A, Gelhard R, Insel T: The ontogeny of excitatory amino acid receptors in the rat forebrain-II. Kainic acid receptors. Neuroscience 1990, 35:45-51.
19. Meldrum B, Garthwaite J: Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990, 11:379-387.
20. Sayers T, Macher I, Chung J, Kugler E: The production of tumor necrosis factor by mouse bone marrow-derived macrophages in response to bacterial lipopolysaccharide and a chemically synthesized monosaccharide precursor. J Immunol 1987, 138:2935-2940.
21. Gelbard H, Dzenko K, DiLoreto D, del Cerro C, del Cerro M, Epstein L: Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev Neurosci 1993, 15:417-422.
22. Westmoreland S, Kolson D, Gonzales-Scarano F: Toxicity of TNFalpha and platelet activating factor for human NT2N neurons: a tissue culture model for human immunodeficiency virus dementia. J Neurovirol 1996, 2:118-126.
23. Barone F, Arvin B, White R, Miller A, Webb C, Willette R, et al.: Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997, 28:1233-1244.
24. Balasingam V, Yong V: Attenuation of astroglial reactivity by interleukin-10. J Neurosci 1996, 16:2945-2955.
25. Gehrmann J, Banati R, Wiessner C, Hossmann K, Kreutzberg G: Reactive microglia in cerebral ischaemia: an early mediator of tissue damage? Neuropathol Appl Neurobiol 1995, 21:277-289.
26. Heyes M, Achim C, Wiley C, Major E, Saito K, Markey S: Human microglia convert I-tryptophan into the neurotoxin quinolinic acid. Biochem J 1996, 320:595-597.
27. Mallat M, Chamak B: Brain macrophages: neurotoxic or neurotrophic effector cells? J Leukocyte Biol 1994, 56:416-422.
28. Colton C, Gilbert D: Production of Superoxide anions by a CNS macrophage, the microglia. FEBS Lett 1987, 223:284-288.
29. Kumar K, Evans A: Effect of hypothermia on microglial reaction in ischemic brain. Neuroreport 1997, 8:947-950.
30. Giulian D, Baker T: Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 1986, 6:2163-2178.
31. Mattson MP, Barger SW, Begley JG, Mark RJ: Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol 1995, 46:187-216.
32. Meda L, Cassatella M, Szendrei G, Otvos Jr L, Baron P, Villaiba M, et al.: Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995, 374:647-650.